BMC Cancer

Published by: Biomed Central Ltd  

People

  1. O'Reilly
    O'Reilly
  2. Motzer
    Motzer
  3. Abou-Alfa
    Abou-Alfa
  4. Capanu
    Capanu
  5. Chou
    Chou
  6. Basturk
    Basturk
  7. Brogi
    Brogi
  8. Cercek Hanjis
    Cercek Hanjis
  9. Chi
    Chi
  10. D'Angelica
    D'Angelica

Groups

  1. Department of Medicine (22)
  2. Solid Tumor Oncology Division (22)
  3. Gastrointestinal Oncology Service (8)
  4. Genitourinary Oncology Service (7)
  5. Center for Pancreatic Cancer Research (6)
  6. Survivorship Research (6)
  7. Epidemiology and Biostatistics (3)
  8. GSK Faculty (3)
  9. Population Sciences Research Program (3)
  10. Biostatistics Service (2)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (22)
Groups
  1. Department of Medicine (22)
  2. Solid Tumor Oncology Division (22)
  3. Gastrointestinal Oncology Service (8)
  4. Genitourinary Oncology Service (7)
  5. Center for Pancreatic Cancer Research (6)
  6. Survivorship Research (6)

More Groups

People
  1. Eileen O'Reilly (5)
  2. Robert Motzer (3)
  3. Ghassan Abou-Alfa (2)
  4. Joanne Chou (2)
  5. Marinela Capanu (2)
  6. Alexander Drilon (1)

More People

Years
  1. 2024 (1)
  2. 2022 (4)
  3. 2021 (3)
  4. 2019 (2)
  5. 2018 (5)
  6. 2017 (2)

More Years

Publishers
  1. Biomed Central Ltd (22)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
    Journal Article

    Hitchcock, K. E.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; George, M.; Jee, K. W.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: Analysis from the phase 3 INVICTUS trial
    Journal Article

    Schöffski, P.; George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Serrano, C.; Jones, R. L.; Attia, S.; D’Amato, G.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Rationale and design of ON-TRK: A novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
    Journal Article

    Yang, J. C. H.; Brose, M. S.; Castro, G.; Kim, E. S.; Lassen, U. N.; Leyvraz, S.; Pappo, A.; López‐Ríos, F.; Reeves, J. A.; Fellous, M.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial
    Journal Article

    El-Khoueiry, A. B.; Meyer, T.; Cheng, A. L.; Rimassa, L.; Sen, S.; Milwee, S.; Kelley, R. K.; Abou-Alfa, G. K.
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Relationship between insurance status and interhospital transfers among cancer patients in the United States
    Journal Article

    Rubens, M.; Ramamoorthy, V.; Saxena, A.; Appunni, S.; Sundil, S.; Veledar, E.; McGranaghan, P.; Tonse, R.; Fitz, S. J. T.; Chuong, M. D.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
    Journal Article

    Powles, T.; Choueiri, T. K.; Motzer, R. J.; Jonasch, E.; Pal, S.; Tannir, N. M.; Signoretti, S.; Kaldate, R.; Scheffold, C.; Wang, E.; more...
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
    Journal Article

    Grivas, P.; Loriot, Y.; Morales-Barrera, R.; Teo, M. Y.; Zakharia, Y.; Feyerabend, S.; Vogelzang, N. J.; Grande, E.; Adra, N.; Alva, A.; more...
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
    Journal Article

    Askan, G.; Sahin, I. H.; Chou, J. F.; Yavas, A.; Capanu, M.; Iacobuzio-Donahue, C. A.; Basturk, O.; O’Reilly, E. M.
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Effects of adjunct testosterone on cardiac morphology and function in advanced cancers: An ancillary analysis of a randomized controlled trial
    Journal Article

    Scott, J. M.; Dillon, E. L.; Kinsky, M.; Chamberlain, A.; McCammon, S.; Jupiter, D.; Willis, M.; Hatch, S.; Richardson, G.; Danesi, C.; more...
    BMC Cancer (2019)

    Fulltext@MSK | Save
  • Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial
    Journal Article

    Buisman, F. E.; Homs, M. Y. V.; Grünhagen, D. J.; Filipe, W. F.; Bennink, R. J.; Besselink, M. G. H.; Borel Rinkes, I. H. M.; Bruijnen, R. C. G.; Cercek, A.; D’Angelica, M. I.; more...
    BMC Cancer (2019)

    Fulltext@MSK | Save

    • BMC Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 14712407 Estilo et al Licensee Biomed Central Ltd
    BMC Cancer 14712407 Benchikh et al Licensee Biomed Central Ltd
    BMC Cancer 14712407 The Author(s) 2024
    BMC Cancer 1471-2407 Unknown
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 1471-2407 Biomed Central Ltd
    Bmc Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 14712407 The Author(s)
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 14712407 Unknown
    BMC Cancer 1471-2407 Biomed Central Ltd
    Bmc Cancer 1471-2407 Bmc
    BMC Cancer 14712407 de Moor et al Licensee Biomed Central Ltd
    BMC Cancer 14712407 Lavarino et al Licensee Biomed Central Ltd
    BMC Cancer 14712407 2022, The Author(s)
    BMC Cancer 14712407 Quintana et al Licensee Biomed Central Ltd
    BMC Cancer 1470-2045 Unknown
    BMC Cancer 1471-2407 Biomed Central Ltd
    BMC Cancer 1471-2407 Biomed Central Ltd